Adherence to Acute Migraine Medication: What Does It Mean, Why Does It Matter?

被引:33
作者
Katic, Bozena J. [1 ,2 ]
Krause, Steven J. [3 ]
Tepper, Stewart J. [3 ]
Hu, Henry X. [1 ]
Bigal, Marcelo E. [4 ,5 ]
机构
[1] Merck & Co Inc, Global Outcomes Res, Whitehouse Stn, NJ USA
[2] Temple Univ, Sch Pharm, Ctr Pharmaceut Hlth Serv Res, Philadelphia, PA 19122 USA
[3] Cleveland Clin, Neurol Inst, Ctr Headache & Pain, Cleveland, OH 44106 USA
[4] Merck & Co Inc, Sci Affairs, Whitehouse Stn, NJ USA
[5] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源
HEADACHE | 2010年 / 50卷 / 01期
关键词
medication adherence; triptan; underutilization; medication compliance; acute migraine treatment; migraine treatment decision; BEHAVIORAL FACILITATION; PROPHYLACTIC MEDICATION; CONSULTING BEHAVIOR; PATIENT-ADHERENCE; FUTURE-DIRECTIONS; CLINICAL-PRACTICE; HEADACHE PATIENTS; DECISION-MAKING; ANALGESIC USE; TRIPTANS;
D O I
10.1111/j.1526-4610.2009.01535.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Proper use of medications is an important part of successfully managing migraine headache, yet migraineurs frequently switch, discontinue, or delay taking effective prescription therapies such as triptans. Medication persistence in the treatment of chronic-episodic disorders such as migraine is not well understood. In this article we review this topic, by critically reviewing studies conducted using pharmacy claims, clinical records, survey, and patient-reported data to explore acute medication use for migraine headache. While efficacy, cost, drug tolerability, and side effects impact whether a patient takes migraine medication, low perceived disease importance and factors related to the patient's internal decision-making process play a strong role in the sustained use of acute medication for migraine attack. We propose a model that combines the patient's perceived severity of migraine, their beliefs regarding the safety of acute medications, and factors related to the physician-patient relationship to identify migraineurs at high risk for medication adherence problems.
引用
收藏
页码:117 / 129
页数:13
相关论文
共 66 条
[1]   Headache and analgesic use in Sweden [J].
Antonov, K ;
Isacson, D .
HEADACHE, 1998, 38 (02) :97-104
[2]   Prescription and nonprescription analgesic use in Sweden [J].
Antonov, KIM ;
Isacson, DGL .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (04) :485-494
[3]   Managing the "difficult" headache patient [J].
Baskin, S. M. .
NEUROLOGICAL SCIENCES, 2007, 28 (Suppl 2) :S78-S83
[4]   Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand? [J].
Bigal, Marcelo ;
Krymchantowski, Abouch Valenty ;
Lipton, Richard B. .
HEADACHE, 2009, 49 (07) :1028-1041
[5]   Excessive acute migraine medication use and migraine progression [J].
Bigal, Marcelo E. ;
Lipton, Richard B. .
NEUROLOGY, 2008, 71 (22) :1821-1828
[6]   Pathways to the best fit of triptans for migraine patients [J].
Buzzi, M. G. .
CEPHALALGIA, 2008, 28 :21-27
[7]   Predictors of Adherence to Triptans: Factors of Sustained vs Lapsed Users [J].
Cady, Roger K. ;
Maizels, Morris ;
Reeves, Dennis L. ;
Levinson, Daniel M. ;
Evans, Judith K. .
HEADACHE, 2009, 49 (03) :386-394
[8]   A systematic review of the associations between dose regimens and medication compliance [J].
Claxton, AJ ;
Cramer, J ;
Pierce, C .
CLINICAL THERAPEUTICS, 2001, 23 (08) :1296-1310
[9]   INTENTIONAL PRESCRIPTION NON-ADHERENCE (NON-COMPLIANCE) BY THE ELDERLY [J].
COOPER, JK ;
LOVE, DW ;
RAFFOUL, PR .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1982, 30 (05) :329-333
[10]   Medication compliance and persistence: Terminology and definitions [J].
Cramer, Joyce A. ;
Roy, Anuja ;
Burrell, Anita ;
Fairchild, Carol J. ;
Fuldeore, Mahesh J. ;
Ollendorf, Daniel A. ;
Wong, Peter K. .
VALUE IN HEALTH, 2008, 11 (01) :44-47